HomepageMedicineAstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis Medicine AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis admin Posted on May 8, 2024 Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostMore ghost malls in the making as consumers shun poorly managed shopping centres Next PostHow Much Money Did This Year’s Met Gala Raise? You Might Also Like Medicine FDA Approves Vertex Pharmaceuticals’ First-in-Class Non-Opioid Journavx for Moderate-to-Severe Acute Pain admin February 2, 2025 Medicine Department of Defense Awards Emergent BioSolutions With $235.8 Million Contract for Anthrax Vaccine admin January 15, 2024 Medicine Texas Biomed Developing Potential Bird Flu Vaccine admin April 19, 2024 Medicine Poseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos admin May 6, 2024
Medicine FDA Approves Vertex Pharmaceuticals’ First-in-Class Non-Opioid Journavx for Moderate-to-Severe Acute Pain admin February 2, 2025
Medicine Department of Defense Awards Emergent BioSolutions With $235.8 Million Contract for Anthrax Vaccine admin January 15, 2024
Medicine Poseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos admin May 6, 2024